Immutep News - IMMP

Company Name	Stock Ticker Symbol	Market	Type
Immutep Ltd	IMMP	NASDAQ	Depository Receipt

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	2.20	04:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
				2.20

more quote information »

Recent News

Date	Time	Source	Heading
4/18/2024	08:00	GLOBE	Immutep Appoints Leading Research Institute to Conduct..
4/17/2024	08:00	GLOBE	Immutep Receives Positive Feedback from the Spanish..
3/05/2024	08:00	GLOBE	Immutep Announces First Clinical Data from 90mg Dosing of..
1/30/2024	16:01	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/30/2024	08:00	GLOBE	Immutep Quarterly Activities Report Q2 FY24
1/04/2024	08:00	GLOBE	First Patient Dosed in Trial Evaluating Efti and the..
12/21/2023	08:00	GLOBE	Immutep Receives Constructive Regulatory Feedback on..
12/21/2023	06:06	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/07/2023	08:00	GLOBE	Immutep Receives A$2.6 million R&D Tax Incentive from French..
11/22/2023	08:00	GLOBE	Immutep Announces Site Expansion for INSIGHT-003 Phase I..
11/09/2023	08:00	GLOBE	Immutep Completes Enrollment in TACTI-003 Phase IIb Trial of..
11/06/2023	08:00	GLOBE	Immutep Announces Completion of the Safety Lead-In and..
11/03/2023	12:00	GLOBE	Immutep Announces New Biomarker Data from TACTI-002 Phase II..
11/03/2023	06:06	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/02/2023	08:00	GLOBE	Immutep to Participate in November Investor Events
10/31/2023	08:00	GLOBE	Immutep Quarterly Activities Report Q1 FY24
10/25/2023	08:00	GLOBE	Immutep receives ~A$1.13 million R&D Tax Incentive
10/25/2023	06:07	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/24/2023	08:00	GLOBE	Immutep Reports Promising Clinical Data from INSIGHT-003..
10/24/2023	06:35	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/23/2023	08:00	GLOBE	Immutep’s Efti in Combination with KEYTRUDA® Generates..
10/16/2023	08:00	GLOBE	Immutep Announces Publication of Abstracts at ESMO Congress..
10/03/2023	08:00	GLOBE	Immutep Announces Abstract Accepted for Presentation at the..
9/21/2023	08:00	GLOBE	Commercial Manufacturing of Eftilagimod Alpha at 2000L Scale..
9/05/2023	09:00	GLOBE	Immutep to Participate in September Investor Conferences
8/01/2023	08:00	GLOBE	Immutep Receives Positive Scientific Advice from European..
7/31/2023	08:00	GLOBE	Immutep to Present Overall Survival Data in 1st Line..
7/28/2023	08:00	GLOBE	First Patient Dosed in Chemotherapy-Free Triple Combination..
7/28/2023	06:31	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
6/27/2023	08:00	GLOBE	Immutep Secures Third United States Patent for Eftilagimod..
6/20/2023	08:00	GLOBE	Immutep Granted United States Patent for IMP761, a..
6/07/2023	08:00	GLOBE	Immutep to Participate at the Jefferies Healthcare..
6/05/2023	08:00	GLOBE	Immutep Reports Final Positive Data in 2nd Line Head and..
6/02/2023	08:00	GLOBE	Immutep Successfully Completes Institutional Placement and..
5/29/2023	08:00	GLOBE	Immutep Selects Charles River Laboratories for IMP761’s GLP..
5/26/2023	08:00	GLOBE	Immutep Announces Publication of Abstracts for ASCO 2023..
5/25/2023	08:00	GLOBE	Immutep Doses First Patient in AIPAC-003 Phase II/III Trial..
5/24/2023	08:00	GLOBE	Immutep Announces Promising New Clinical Data from Triple..
5/17/2023	08:00	GLOBE	Immutep’s Efti in Combination with Pembrolizumab Achieves..
5/16/2023	08:00	GLOBE	Immutep Receives Positive Feedback from FDA on Late-Stage..
5/09/2023	08:00	GLOBE	Immutep to Participate in the JMP Securities Life Sciences..
5/02/2023	08:00	GLOBE	Immutep Announces KOL Event Focused on Eftilagimod Alpha in..
5/01/2023	08:00	GLOBE	Immutep Receives Approval to Initiate INSIGHT-005 Trial..
4/27/2023	08:00	GLOBE	Immutep Quarterly Activities Report
4/26/2023	10:00	GLOBE	Immutep Announces Presentation of New TACTI-002 Data at the..
4/26/2023	08:00	GLOBE	Immutep Appoints Dr. Florian Vogl as Chief Medical Officer